Burning Rock Biotech Files 6-K Report

Ticker: BNR · Form: 6-K · Filed: Sep 8, 2025 · CIK: 1792267

Sentiment: neutral

Topics: reporting, foreign-private-issuer

TL;DR

Burning Rock Biotech filed a 6-K, standard reporting for foreign issuers.

AI Summary

Burning Rock Biotech Ltd. filed a Form 6-K on September 8, 2025, reporting for the month of September 2025. The filing is from their principal executive offices located at No. 5 Xingdao Ring Road North, International Bio Island, Guangzhou, Guangdong, People's Republic of China. The company is a foreign private issuer and will file annual reports under Form 20-F.

Why It Matters

This filing indicates ongoing reporting requirements for Burning Rock Biotech Ltd. as a foreign private issuer, providing updates to investors.

Risk Assessment

Risk Level: low — This is a routine filing for a foreign private issuer and does not contain specific financial or operational news that would indicate a change in risk.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information which the registrant may be required to disclose or make public pursuant to the laws of its home country or which it may make or be required to make public pursuant to the laws of any stock exchange on which it has securities listed.

What is Burning Rock Biotech Ltd.'s filing status?

Burning Rock Biotech Ltd. is a foreign private issuer and files reports under Form 6-K and will file annual reports under Form 20-F.

Where are Burning Rock Biotech Ltd.'s principal executive offices located?

The principal executive offices are located at No. 5 Xingdao Ring Road North, International Bio Island, Guangzhou, Guangdong, People's Republic of China.

What period does this Form 6-K report cover?

This Form 6-K reports for the month of September 2025.

What specific exhibits are excluded from incorporation by reference in this filing?

Exhibit 99.1 is incorporated by reference, excluding the paragraphs under the heading 'Non-GAAP Measures,' the table under the heading 'Burning Rock Biotech Limited Reconciliations of GAAP and Non-GAAP Results,' and other discussions on non-GAAP measures.

Filing Stats: 219 words · 1 min read · ~1 pages · Grade level 13.5 · Accepted 2025-09-08 06:06:26

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Burning Rock Biotech Limited By: /s/ Yusheng Han Name: Yusheng Han Title: Chief Executive officer Date: September 8, 2025 4

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing